Alpha Teknova, Inc. (NASDAQ:TKNO) Shares Sold by Conestoga Capital Advisors LLC

Conestoga Capital Advisors LLC trimmed its position in shares of Alpha Teknova, Inc. (NASDAQ:TKNO - Free Report) by 21.3% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 192,274 shares of the company's stock after selling 52,070 shares during the quarter. Conestoga Capital Advisors LLC owned approximately 0.36% of Alpha Teknova worth $998,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of TKNO. JPMorgan Chase & Co. raised its position in shares of Alpha Teknova by 622.5% during the 4th quarter. JPMorgan Chase & Co. now owns 4,400 shares of the company's stock worth $37,000 after purchasing an additional 3,791 shares during the last quarter. Mount Lucas Management LP purchased a new position in Alpha Teknova during the fourth quarter worth $75,000. Two Sigma Investments LP raised its holdings in shares of Alpha Teknova by 46.2% in the fourth quarter. Two Sigma Investments LP now owns 15,148 shares of the company's stock worth $126,000 after acquiring an additional 4,789 shares during the last quarter. NewEdge Advisors LLC lifted its position in shares of Alpha Teknova by 14.3% in the fourth quarter. NewEdge Advisors LLC now owns 15,632 shares of the company's stock valued at $131,000 after acquiring an additional 1,953 shares in the last quarter. Finally, Barclays PLC purchased a new stake in shares of Alpha Teknova in the fourth quarter valued at $132,000. Institutional investors and hedge funds own 13.81% of the company's stock.

Alpha Teknova Price Performance

Alpha Teknova stock traded up $0.05 during midday trading on Friday, reaching $5.56. 200,340 shares of the company were exchanged, compared to its average volume of 407,061. The firm's 50-day simple moving average is $6.10 and its 200-day simple moving average is $6.93. Alpha Teknova, Inc. has a 1 year low of $1.16 and a 1 year high of $10.37. The company has a market capitalization of $297.13 million, a price-to-earnings ratio of -11.58 and a beta of 0.40. The company has a debt-to-equity ratio of 0.17, a quick ratio of 4.71 and a current ratio of 5.64.

Alpha Teknova (NASDAQ:TKNO - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The company reported ($0.09) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.11) by $0.02. The company had revenue of $9.60 million for the quarter, compared to analysts' expectations of $9.41 million. Alpha Teknova had a negative net margin of 60.90% and a negative return on equity of 28.48%. On average, analysts anticipate that Alpha Teknova, Inc. will post -0.58 EPS for the current year.

Alpha Teknova Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.